This report contains market size and forecasts of Artificial Blood in Global, including the following market information:
Global Artificial Blood Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Artificial Blood market was valued at 3130.7 million in 2020 and is projected to reach US$ 4770 million by 2027, at a CAGR of 11.1% during the forecast period.
Publisher has surveyed the Artificial Blood companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Artificial Blood Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Artificial Blood Market Segment Percentages, By Type, 2020 (%)
Human Blood
Synthetic Blood
Animal Blood
China Artificial Blood Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Artificial Blood Market Segment Percentages, By Application, 2020 (%)
Hemoglobin-Based Oxygen Carriers (HBOCs)
Perflurocarbon Emulsions (PFCEs)
Global Artificial Blood Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Artificial Blood Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Artificial Blood Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Artificial Blood Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Dextro-Sang Corporation
BioPure Corporation
Sangart
Northfield Laboratories
Baxter International
Dentritech
FluorO2 Therapeutics
Nuvox Pharma
Alpha Therapeutic Corporation
HemoBioTech
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Artificial Blood Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Artificial Blood Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Artificial Blood Overall Market Size
2.1 Global Artificial Blood Market Size: 2021 VS 2027
2.2 Global Artificial Blood Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Artificial Blood Players in Global Market
3.2 Top Global Artificial Blood Companies Ranked by Revenue
3.3 Global Artificial Blood Revenue by Companies
3.4 Top 3 and Top 5 Artificial Blood Companies in Global Market, by Revenue in 2020
3.5 Global Companies Artificial Blood Product Type
3.6 Tier 1, Tier 2 and Tier 3 Artificial Blood Players in Global Market
3.6.1 List of Global Tier 1 Artificial Blood Companies
3.6.2 List of Global Tier 2 and Tier 3 Artificial Blood Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Artificial Blood Market Size Markets, 2021 & 2027
4.1.2 Human Blood
4.1.3 Synthetic Blood
4.1.4 Animal Blood
4.2 By Type - Global Artificial Blood Revenue & Forecasts
4.2.1 By Type - Global Artificial Blood Revenue, 2016-2021
4.2.2 By Type - Global Artificial Blood Revenue, 2022-2027
4.2.3 By Type - Global Artificial Blood Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Artificial Blood Market Size, 2021 & 2027
5.1.2 Hemoglobin-Based Oxygen Carriers (HBOCs)
5.1.3 Perflurocarbon Emulsions (PFCEs)
5.2 By Application - Global Artificial Blood Revenue & Forecasts
5.2.1 By Application - Global Artificial Blood Revenue, 2016-2021
5.2.2 By Application - Global Artificial Blood Revenue, 2022-2027
5.2.3 By Application - Global Artificial Blood Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Artificial Blood Market Size, 2021 & 2027
6.2 By Region - Global Artificial Blood Revenue & Forecasts
6.2.1 By Region - Global Artificial Blood Revenue, 2016-2021
6.2.2 By Region - Global Artificial Blood Revenue, 2022-2027
6.2.3 By Region - Global Artificial Blood Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Artificial Blood Revenue, 2016-2027
6.3.2 US Artificial Blood Market Size, 2016-2027
6.3.3 Canada Artificial Blood Market Size, 2016-2027
6.3.4 Mexico Artificial Blood Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Artificial Blood Revenue, 2016-2027
6.4.2 Germany Artificial Blood Market Size, 2016-2027
6.4.3 France Artificial Blood Market Size, 2016-2027
6.4.4 U.K. Artificial Blood Market Size, 2016-2027
6.4.5 Italy Artificial Blood Market Size, 2016-2027
6.4.6 Russia Artificial Blood Market Size, 2016-2027
6.4.7 Nordic Countries Artificial Blood Market Size, 2016-2027
6.4.8 Benelux Artificial Blood Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Artificial Blood Revenue, 2016-2027
6.5.2 China Artificial Blood Market Size, 2016-2027
6.5.3 Japan Artificial Blood Market Size, 2016-2027
6.5.4 South Korea Artificial Blood Market Size, 2016-2027
6.5.5 Southeast Asia Artificial Blood Market Size, 2016-2027
6.5.6 India Artificial Blood Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Artificial Blood Revenue, 2016-2027
6.6.2 Brazil Artificial Blood Market Size, 2016-2027
6.6.3 Argentina Artificial Blood Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Artificial Blood Revenue, 2016-2027
6.7.2 Turkey Artificial Blood Market Size, 2016-2027
6.7.3 Israel Artificial Blood Market Size, 2016-2027
6.7.4 Saudi Arabia Artificial Blood Market Size, 2016-2027
6.7.5 UAE Artificial Blood Market Size, 2016-2027
7 Players Profiles
7.1 Dextro-Sang Corporation
7.1.1 Dextro-Sang Corporation Corporate Summary
7.1.2 Dextro-Sang Corporation Business Overview
7.1.3 Dextro-Sang Corporation Artificial Blood Major Product Offerings
7.1.4 Dextro-Sang Corporation Artificial Blood Revenue in Global (2016-2021)
7.1.5 Dextro-Sang Corporation Key News
7.2 BioPure Corporation
7.2.1 BioPure Corporation Corporate Summary
7.2.2 BioPure Corporation Business Overview
7.2.3 BioPure Corporation Artificial Blood Major Product Offerings
7.2.4 BioPure Corporation Artificial Blood Revenue in Global (2016-2021)
7.2.5 BioPure Corporation Key News
7.3 Sangart
7.3.1 Sangart Corporate Summary
7.3.2 Sangart Business Overview
7.3.3 Sangart Artificial Blood Major Product Offerings
7.3.4 Sangart Artificial Blood Revenue in Global (2016-2021)
7.3.5 Sangart Key News
7.4 Northfield Laboratories
7.4.1 Northfield Laboratories Corporate Summary
7.4.2 Northfield Laboratories Business Overview
7.4.3 Northfield Laboratories Artificial Blood Major Product Offerings
7.4.4 Northfield Laboratories Artificial Blood Revenue in Global (2016-2021)
7.4.5 Northfield Laboratories Key News
7.5 Baxter International
7.5.1 Baxter International Corporate Summary
7.5.2 Baxter International Business Overview
7.5.3 Baxter International Artificial Blood Major Product Offerings
7.5.4 Baxter International Artificial Blood Revenue in Global (2016-2021)
7.5.5 Baxter International Key News
7.6 Dentritech
7.6.1 Dentritech Corporate Summary
7.6.2 Dentritech Business Overview
7.6.3 Dentritech Artificial Blood Major Product Offerings
7.6.4 Dentritech Artificial Blood Revenue in Global (2016-2021)
7.6.5 Dentritech Key News
7.7 FluorO2 Therapeutics
7.7.1 FluorO2 Therapeutics Corporate Summary
7.7.2 FluorO2 Therapeutics Business Overview
7.7.3 FluorO2 Therapeutics Artificial Blood Major Product Offerings
7.4.4 FluorO2 Therapeutics Artificial Blood Revenue in Global (2016-2021)
7.7.5 FluorO2 Therapeutics Key News
7.8 Nuvox Pharma
7.8.1 Nuvox Pharma Corporate Summary
7.8.2 Nuvox Pharma Business Overview
7.8.3 Nuvox Pharma Artificial Blood Major Product Offerings
7.8.4 Nuvox Pharma Artificial Blood Revenue in Global (2016-2021)
7.8.5 Nuvox Pharma Key News
7.9 Alpha Therapeutic Corporation
7.9.1 Alpha Therapeutic Corporation Corporate Summary
7.9.2 Alpha Therapeutic Corporation Business Overview
7.9.3 Alpha Therapeutic Corporation Artificial Blood Major Product Offerings
7.9.4 Alpha Therapeutic Corporation Artificial Blood Revenue in Global (2016-2021)
7.9.5 Alpha Therapeutic Corporation Key News
7.10 HemoBioTech
7.10.1 HemoBioTech Corporate Summary
7.10.2 HemoBioTech Business Overview
7.10.3 HemoBioTech Artificial Blood Major Product Offerings
7.10.4 HemoBioTech Artificial Blood Revenue in Global (2016-2021)
7.10.5 HemoBioTech Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Artificial Blood Market Opportunities & Trends in Global Market
Table 2. Artificial Blood Market Drivers in Global Market
Table 3. Artificial Blood Market Restraints in Global Market
Table 4. Key Players of Artificial Blood in Global Market
Table 5. Top Artificial Blood Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Artificial Blood Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Artificial Blood Revenue Share by Companies, 2016-2021
Table 8. Global Companies Artificial Blood Product Type
Table 9. List of Global Tier 1 Artificial Blood Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Artificial Blood Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Artificial Blood Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Artificial Blood Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Artificial Blood Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Artificial Blood Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Artificial Blood Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Artificial Blood Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Artificial Blood Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Artificial Blood Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Artificial Blood Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Artificial Blood Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Artificial Blood Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Artificial Blood Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Artificial Blood Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Artificial Blood Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Artificial Blood Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Artificial Blood Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Artificial Blood Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Artificial Blood Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Artificial Blood Revenue, (US$, Mn), 2022-2027
Table 30. Dextro-Sang Corporation Corporate Summary
Table 31. Dextro-Sang Corporation Artificial Blood Product Offerings
Table 32. Dextro-Sang Corporation Artificial Blood Revenue (US$, Mn), (2016-2021)
Table 33. BioPure Corporation Corporate Summary
Table 34. BioPure Corporation Artificial Blood Product Offerings
Table 35. BioPure Corporation Artificial Blood Revenue (US$, Mn), (2016-2021)
Table 36. Sangart Corporate Summary
Table 37. Sangart Artificial Blood Product Offerings
Table 38. Sangart Artificial Blood Revenue (US$, Mn), (2016-2021)
Table 39. Northfield Laboratories Corporate Summary
Table 40. Northfield Laboratories Artificial Blood Product Offerings
Table 41. Northfield Laboratories Artificial Blood Revenue (US$, Mn), (2016-2021)
Table 42. Baxter International Corporate Summary
Table 43. Baxter International Artificial Blood Product Offerings
Table 44. Baxter International Artificial Blood Revenue (US$, Mn), (2016-2021)
Table 45. Dentritech Corporate Summary
Table 46. Dentritech Artificial Blood Product Offerings
Table 47. Dentritech Artificial Blood Revenue (US$, Mn), (2016-2021)
Table 48. FluorO2 Therapeutics Corporate Summary
Table 49. FluorO2 Therapeutics Artificial Blood Product Offerings
Table 50. FluorO2 Therapeutics Artificial Blood Revenue (US$, Mn), (2016-2021)
Table 51. Nuvox Pharma Corporate Summary
Table 52. Nuvox Pharma Artificial Blood Product Offerings
Table 53. Nuvox Pharma Artificial Blood Revenue (US$, Mn), (2016-2021)
Table 54. Alpha Therapeutic Corporation Corporate Summary
Table 55. Alpha Therapeutic Corporation Artificial Blood Product Offerings
Table 56. Alpha Therapeutic Corporation Artificial Blood Revenue (US$, Mn), (2016-2021)
Table 57. HemoBioTech Corporate Summary
Table 58. HemoBioTech Artificial Blood Product Offerings
Table 59. HemoBioTech Artificial Blood Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Artificial Blood Segment by Type
Figure 2. Artificial Blood Segment by Application
Figure 3. Global Artificial Blood Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Artificial Blood Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Artificial Blood Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Artificial Blood Revenue in 2020
Figure 8. By Type - Global Artificial Blood Revenue Market Share, 2016-2027
Figure 9. By Application - Global Artificial Blood Revenue Market Share, 2016-2027
Figure 10. By Region - Global Artificial Blood Revenue Market Share, 2016-2027
Figure 11. By Country - North America Artificial Blood Revenue Market Share, 2016-2027
Figure 12. US Artificial Blood Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Artificial Blood Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Artificial Blood Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Artificial Blood Revenue Market Share, 2016-2027
Figure 16. Germany Artificial Blood Revenue, (US$, Mn), 2016-2027
Figure 17. France Artificial Blood Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Artificial Blood Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Artificial Blood Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Artificial Blood Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Artificial Blood Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Artificial Blood Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Artificial Blood Revenue Market Share, 2016-2027
Figure 24. China Artificial Blood Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Artificial Blood Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Artificial Blood Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Artificial Blood Revenue, (US$, Mn), 2016-2027
Figure 28. India Artificial Blood Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Artificial Blood Revenue Market Share, 2016-2027
Figure 30. Brazil Artificial Blood Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Artificial Blood Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Artificial Blood Revenue Market Share, 2016-2027
Figure 33. Turkey Artificial Blood Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Artificial Blood Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Artificial Blood Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Artificial Blood Revenue, (US$, Mn), 2016-2027
Figure 37. Dextro-Sang Corporation Artificial Blood Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. BioPure Corporation Artificial Blood Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Sangart Artificial Blood Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Northfield Laboratories Artificial Blood Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Baxter International Artificial Blood Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Dentritech Artificial Blood Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. FluorO2 Therapeutics Artificial Blood Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Nuvox Pharma Artificial Blood Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Alpha Therapeutic Corporation Artificial Blood Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. HemoBioTech Artificial Blood Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Dextro-Sang Corporation
BioPure Corporation
Sangart
Northfield Laboratories
Baxter International
Dentritech
FluorO2 Therapeutics
Nuvox Pharma
Alpha Therapeutic Corporation
HemoBioTech